Introduction {#sec1}
============

Sesquiterpenoids are considered to be the most diverse group of terpenoids containing a large variety of chemical structures that present different forms of derivation and cyclization from farnesyl diphosphate (FPP).^[@ref1],[@ref2]^ The humulene-type, an 11-membered macrocyclic sesquiterpenoid, is broadly found in plants, and previous reports have demonstrated various kinds of biological activities such as antitumor, anti-inflammatory, antibacterial, antiviral, and other bioactivities.^[@ref3]−[@ref5]^

The genus *Anaxagorea* (Annonaceae) comprises 30 species distributed in the neotropics and tropical Asia.^[@ref6]^ Previous phytochemical studies with plants of this genus revealed the presence of xanthones, flavonoids,^[@ref7]−[@ref9]^ neolignans,^[@ref10]^ terpenoids, and alkaloids,^[@ref11]−[@ref13]^ with some of them exhibiting remarkable biological activities. The analysis of the essential oil from the leaves of *Anaxagorea brevipes* has revealed the presence of mono- and sesquiterpenes such as α-, β-, and γ-eudesmol, guaiol, and caryophyllene oxide. In addition, its biological evaluation showed antimicrobial activity against Gram-positive bacteria and yeast and antiproliferative activity against breast, lung, and prostate cancer cell lines.^[@ref11]^ An interesting sesquiterpene called nordine besides copyrine alkaloids has been isolated from *A. javanica*, and some of these compounds have been assayed for nitric oxide (NO) inhibition.^[@ref13]^*A. dolichocarpa*, widely distributed in South America,^[@ref14]^ is found in Brazil mainly in the North and Northeast regions.^[@ref15]^ Previous works exploring different parts of this plant reported the isolation of aporphine and azaphenanthrene alkaloids,^[@ref16],[@ref17]^ the identification of mono- and sesquiterpenes,^[@ref12],[@ref18]^ the phenolic quantification and determination of its antioxidant activity,^[@ref19]^ and a phytochemical screening and cytotoxicity evaluation of its extract.^[@ref20]^

The gradual emergence of active agents derived from the plant kingdom into the fight against cancer has gained importance in the last decade.^[@ref21]^ These compounds have the potential to be harnessed for preventative strategies, standalone treatments, or complementary therapeutics in combination with traditional pharmacological interventions.^[@ref22]^ In addition, the literature has shown exciting data with respect to potential of natural compounds and their analogues in cancer prevention and treatment.^[@ref23]^

In a continuing effort to isolate active compounds from plants in Brazil's semiarid area and motivated by the promising bioactivities and diversity of sesquiterpenoid structures, the ethanol extract of *A. dolichocarpa* roots was investigated. Thus, we describe here the isolation and structural elucidation of six humulene-type sesquiterpenoids (**1**--**6**). Furthermore, compounds **3**, **4**, and **6** were tested for cytotoxicity.

Results and Discussion {#sec2}
======================

The roots of *A. dolichocarpa* were dried and extracted with ethanol three times at room temperature. The ethanolic extract was suspended in MeOH-H~2~O (7:3) and sequentially partitioned with *n*-hexane, chloroform, and ethyl acetate (EtOAc). The *n*-hexane- and chloroform-soluble phases were fractionated by silica gel chromatography column and medium-pressure liquid chromatography, respectively. The obtained fractions were then purified by preparative HPLC to yield the unprecedented macrocyclic humulene-type sesquiterpenoids dolichocarpols A (**1**) and E (**5**) from the hexane phase and dolichocarpols B-D (**1**--**4**) and F (**6**) from the chloroform phase. The structures were proposed after 1D- and 2D-NMR, IR, HRESIMS, ESIMS/MS, and experimental and calculated electronic circular dichroism (ECD) data analysis.

Compound **1** was isolated as a colorless oil. Its IR spectrum showed a hydroxyl group (3466 cm^--1^) and a carbonyl group (1706 cm^--1^). The molecular formula was determined as C~15~H~24~O~3~ by HRESIMS based on the ion at *m*/*z* 275.1614 \[M + Na\]^+^ (calcd for C~15~H~24~O~3~Na, 275.1618, Δ = 1.2 ppm), corresponding to four indices of hydrogen deficiency. Of these, the ^13^C NMR and DEPT spectra of **1** showed that one was associated with an olefinic group (δ~C~ 134.3, 133.2) and another with a carbonyl group (δ~C~ 168.8). Additionally, the spectrum showed signals assigned to two oxygenated carbons (δ~C~ 83.2, 82.3), one non-hydrogenated carbon (δ~C~ 39.3), one methine carbon (δ~C~ 37.7), five methylene carbons (δ~C~ 40.2, 31.7, 28.9, 27.3, 22.8), and three methyl carbons (δ~C~ 25.9, 22.0, 20.4) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). In the ^1^H NMR spectrum, methyl groups could be inferred from two signals for tertiary methyl protons at δ~H~ 1.08 (s) and 0.82 (s) and one secondary methyl at 0.81 (d, *J* = 6.4 Hz), an olefinic proton at δ~H~ 5.84 (m), and two oxymethine proton at δ~H~ 4.58 (ddd, *J* = 9.2, 6.0, 2.0 Hz) and 3.10 (dl, *J* = 8.4 Hz) ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The comparison of these 1D NMR spectral data with those of nordine isolated from *A. javanica*([@ref13]) suggested that compound **1** was a macrocyclic humulene-type sesquiterpenoid as shown in [Chart [1](#cht1){ref-type="chart"}](#cht1){ref-type="chart"}. In the HMBC spectrum, the correlations observed from H-10 to C-14, C-15, C-1, C-8, and C-9 and from H~2~-1 to C-2 and C-3 localized a Δ^2(3)^ olefinic double bond ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Moreover, correlations from H-6 to C-7, C-8, C-13, and C-12 and from H-2 and H~2~-4 to C-3 and C-12 in combination with COSY correlations between H-8, H-7, and H-6 indicated an unusual ester fusion between C-6 and C-3. Also, in the COSY spectrum, the correlations between H~2~-1, H-2 and H~2~-4, H~2~-5 established two pairs of allylic protons to C-2 and C-3. The ESIMS/MS spectrum of **1** exhibited ion fragments at *m*/*z* 257 \[M - H~2~O + Na\]^+^ and 217 \[M - C~3~H~6~O + Na\]^+^. The relative configuration was deduced from NOESY experiments. The correlation between H-10, H~3~-14, and H-2 indicated that these protons are cofacial adopting an α-orientation and assigning a β-orientation of OH-10 ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). In addition, the correlation from H-2 to H~3~-14 suggested the *E*-configuration of the Δ^2(3)^ double bond, which is in agreement with an X-ray study that assigns the *E*-configuration to the Δ^2(3)^ double bond of the humulene skeleton.^[@ref24],[@ref25]^ The negative specific rotation (\[*α*\]~D~^25^ −41, CHCl~3~) when compared with other humulenes suggests the α-orientation to H~3~-13 in this type of sesquiterpenoid, and the NOESY cross-peak from H~3~-13 to H-6 revealed that they are cofacial with an α-orientation.^[@ref26]^ The ECD experimental spectra showed a negative Cotton effect at λ 234 nm (Δε −0.89) and a positive one at λ 255 nm (Δε +0.43); thus, the comparison of these with the calculated data allowed determination of the absolute configuration of **1** as (6*R*,7*S*,10*R*) ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). According to these lines of evidence, the structure of **1** was defined as humulene-type sesquiterpenoid named dolichocarpol A.

![Chemical Structures of Isolated Compounds **1**--**6** from Roots of *A. dolichocarpa*](ao0c00690_0001){#cht1}

![Key HMBC and ^1^H-^1^H COSY correlations of compounds **1**--**6**.](ao0c00690_0002){#fig1}

![Key ^1^H-^1^H NOESY correlations of compounds **1**--**6**.](ao0c00690_0003){#fig2}

![Experimental and calculated ECD spectra of compounds **1**--**3** and **6**.](ao0c00690_0004){#fig3}

###### ^13^C (100 and 125 MHz) NMR Spectroscopic Data for Compounds **1**--**6** in CDCl~3~

   no  **1**   **2**[a](#t1fn1){ref-type="table-fn"}   **3**   **4**   **5**   **6**
  ---- ------- --------------------------------------- ------- ------- ------- -------
   1   40.2    45.3                                    47.1    55.4    39.4    33.6
   2   134.3   173.0[b](#t1fn2){ref-type="table-fn"}   213.5   213.2   152.8   52.7
   3   133.2   101.8[b](#t1fn2){ref-type="table-fn"}   47.0    49.4    147.8   74.1
   4   28.9    22.2                                    30.6    32.2    18.1    33.0
   5   22.8    33.6                                    37.5    26.4    26.3    32.9
   6   82.3    67.5                                    75.5    84.6    83.5    215.9
   7   37.7    31.7                                    84.0    69.4    69.9    50.5
   8   31.7    32.2                                    27.7    32.8    34.3    29.9
   9   27.3    26.1                                    29.8    20.9    20.6    23.7
   10  83.2    92.3                                    85.6    73.4    72.7    82.6
   11  39.3    40.0                                    39.6    39.9    36.1    39.5
   12  168.8   170.6[b](#t1fn2){ref-type="table-fn"}   19.3    20.7    195.7   68.3
   13  20.4    14.2                                    20.9    24.7    23.7    30.6
   14  25.9    29.2                                    27.7    27.3    23.7    33.2
   15  22.0    21.9                                    27.6    21.1    22.2    29.2

^13^C NMR (125 MHz).

^13^C NMR (200 MHz).

###### ^1^H (400 and 500 MHz) NMR Spectroscopic Data for Compounds **1**--**6** in CDCl~3~

     no     **1**                        **2**[a](#t2fn1){ref-type="table-fn"}  **3**                 **4**                  **5**                         **6**
  --------- --------------------------- --------------------------------------- --------------------- ---------------------- ----------------------------- -----------------------------
      1     2.88, td (13.6, 0.8)                    2.97, d (19.5)              2.52, d (12.4)        2.34, dd (10.8)        3.12, t (11.2)                1.91, dd (16.0, 4.8)
   1.96, m  2.76, d (19.5)                          1.84, d (12.4)              1.99, dd (10.8)       1.88, dd (11.2, 7.2)   1.66, dd (16.0, 2.8)          
      2     5.84, m                                                                                                          6.52, dd (10.8, 7.2)          2.29, m
      3                                                                         2.74, m               2.71, dd (9.6, 6.8)                                   
      4     2.51, m                                     2.39, m                 1.89, m               1.86, m                2.61, dd (10.8, 1.2)          2.01, dt (13.2, 4.0)
   2.51, m  2.39, m                                     1.37, m                 1.49, m               2.20, dd (13.2, 8.0)   1.74, ddd (13.6, 10.8, 5.6)   
      5     2.18, m                                     1.62, m                 2.05, m               1.77, m                1.85, m                       2.80, ddd (16.4, 13.2, 5.2)
   1.99, m  1.62, m                                     1.62, m                 1.53, m               1.52, m                2.29, m                       
      6     4.58, ddd (9.2, 6.0, 2.0)            3.57, dd (11.0, 4.0)           3.50, dd (5.2, 2.4)   3.52, m                3.58, dd (12.4, 5.6)           
      7     2.22, m                                     2.56, m                                                                                             
      8     1.85, m                                     1.57, m                 1.73, m               1.69, m                1.69, m                       2.29, m
   1.34, m  1.57, m                                     1.62, m                 1.48, m               1.56, m                1.45, ddd (14.8, 12.4, 7.6)   
      9     1.34, m                                     1.57, m                 2.09, m               1.53, m                1.49, m                       1.93--1.91, m
   1.19, m  1.45                                        1.21, m                 1.40, m               1.30, m                                              
     10     3.10, dl (8.4)                          4.07, d (12.0)              3.48, dd (6.8, 4.0)   3.68, m                2.90, dd (11.2, 1.6)          3.52, dd (6.4, 2,4)
     11                                                                                                                                                     
     12                                                                         0.96, d (7.2)         0.96, d (6.8)          9.37, d (0.8)                 3.66, d (14.0)
                                                                                                                             3.26, dd (14.0, 1.6)          
     13     0.81, d (6.4)                            0.84, d (7.0)              1.09, s               0.99, s                0.98, s                       1.09, s
     14     1.08, s                                     1.09, s                 1.24, s               0.91, s                0.84, s                       1.23, s
     15     0.82, s                                     1.07, s                 0.85, s               1.03, s                1.00, s                       1.05, s

^1^H NMR (500 MHz).

Compound **2** was obtained as a colorless oil. Its IR spectrum showed a hydroxyl group (3401 cm^--1^) and a carbonyl group (1671 cm^--1^). The molecular formula was established as C~15~H~24~O~4~ by HRESIMS *m*/*z* 291.1566 \[M + Na\]^+^ (calcd for C~15~H~24~O~4~Na, 291.1567, Δ = 0.1 ppm), indicating four indices of hydrogen deficiency. The ^1^H NMR spectrum of **2** was similar to that of **1** except for the absence of an olefinic proton, thus still having three methyl groups and five methylene groups besides two oxymethine protons and one methine proton ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The ^13^C NMR spectrum (125 MHz/CDCl~3~) exhibited 12 carbon resonances, corresponding to two oxygenated carbons (δ~C~ 92.3, 67.5), one non-hydrogenated carbon (δ~C~ 40.0), one methine carbon (δ~C~ 31.7), five methylene carbons (δ~C~ 45.3, 33.6, 32.2, 26.1, 22.2), and three methyl carbons (δ~C~ 29.2, 21.9, 14.2) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Other three non-hydrogenated carbons (δ~C~ 173.0, 170.6, 101.8) were detected in the 200 MHz (CDCl~3~) ^13^C NMR spectrum ([Figure S21](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00690/suppl_file/ao0c00690_si_001.pdf), Supporting Information). The HSQC spectrum revealed that the chemical shifts at δ~C~ 173.0, 101.8, and 170.6 were observed instead of those at δ~C~ 134.3, 133.2, and 168.8 assigned to C-2, C-3, and C-12 of compound **1**, respectively, and a double bond with the ether bridge between C-10 and C-2. In the ^1^H and ^13^C NMR spectra of **2** ([Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}), the upfield chemical shifts observed for H-10 and C-10 and downfield chemical shifts of H-6 and C-6 supported the opening of the ester bridge C-6 and C-3 to form a C-6 hydroxyl. Similarly, the absence of H-2 and C-2 and downfield chemical shifts for C-2, C-3, and C-12 suggested an ether bridge between C-10 and C-2. In the HMBC spectrum, the correlation from H~2~-1 to C-15, C-14, C-10, C-3, and C-2, together with the correlation from H-10 to C-2 and from H~2~-4 to C-12, corroborated the connectivity between C-10 and C-2 ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). In the ^1^H--^1^H COSY spectrum of **2**, as expected, the correlation H-2/H~2~-1 was not displayed, leaving those between H-10 and H~2~-9, between H-8, H-7, and H~3~-13, and between H-6, H~2~-5, and H~2~-4. The ESIMS/MS spectrum of **2** exhibited ion fragments at *m*/*z* 251 \[M - H~2~O + H\]^+^, *m*/*z* 233 \[M - 2H~2~O + H\]^+^, 215 \[M - 3H~2~O + H\] ^+^, and 205 \[M - H~2~O -- HCOOH + H\]^+^ compatible with a carboxyl group. The insertion of this group at C-3 is compatible with the chemical shift attributed to C-2. The NOESY correlation observed between H-10 and H~3~-14 indicated an α-orientation to these protons ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The multiplicity of the H-6 signal (dd) together with the absence of the ^1^H--^1^H COSY correlation with H-7 suggested that the dihedral angle between these protons is close to 90°. Thus, considering this evidence, the NOESY correlation between H-6 and H-7 indicated that these protons are cofacial with the β-orientation, so OH-6 and H~3~-13 adopted an α-orientation, with a negative specific rotation (\[*α*\]~D~^25^ −15, CHCl~3~). The (6*S*,7*S*,10*R*) absolute configuration of **2** was determined by ECD experimental, with positive Cotton effects at λ 201 nm (Δε +1.55) and λ 243 nm (Δε +1.92), and calculated data ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Therefore, the structure of compound **2**, named dolichocarpol B, was established as shown.

Compound **3** was also purified as a colorless oil. The IR spectrum showed a hydroxyl group (3458 cm^--1^) and a carbonyl group (1703 cm^--1^). The molecular formula of dolichocarpol C (**3**) was deduced as C~15~H~26~O~3~ by HRESIMS at *m*/*z* 277.1773 \[M + Na\]^+^ (calcd for C~15~H~26~O~3~Na, 277.1774, Δ = 0.3 ppm), differing from compound **1** by the absence of the double bond. The 1D NMR data of compound **3** were similar to those of **1** and **2** but with an additional methyl carbon (δ~C~ 19.3) and a ketone carbonyl group (δ~C~ 213.5) instead of carbonyl ester or acid at C-3 ([Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}). In the COSY spectrum, the combination of vicinal homonuclear coupling correlations observed between H-3, H~2~-4, and H~3~-12, between H-10 and H-9, and between H-6 and H~2~-5 indicated an alteration in the junction of the carbon skeleton, compatible with a new bicyclic fusion, and defined the chemical shifts of the methine proton H-3 and oxymethine protons H-10 and H-6 ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). The HMBC cross-peak correlation from H~2~-1 to C-15, C-14, C-10, and C-3 and from H~3~-12, H~2~-4, and H~2~-1 to C-2 established that the ether bridge in **3** continued through C-10 but unlike the previous compounds. Additionally, the correlation from H~3~-13 to C-8, C-7, and C-6 defined the ether bridge between C-10 and C-7. Compound **3** was acetylated, and only one acetate was obtained at C-6 (δ~H~ 4.61, dd, *J* = 5.2, 2.4, H-6). The HMBC spectrum of acetylated **3** ([Figure S21](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00690/suppl_file/ao0c00690_si_001.pdf), Supporting Information) showed correlations from H-6 to C-13, C-8, C-7, C-5, and C-4. This finding confirmed the bridge between C-10 and C-7, and the chemical shift at δ~C~ 84.0 was unequivocally assigned to C-7. The ESIMS/MS spectrum exhibited ion fragments at *m*/*z* 237 \[M - H~2~O + H\]^+^, 219 \[M - 2H~2~O + H\]^+^, and 201 \[M - 3H~2~O + H\]^+^. The analysis of specific rotation (\[*α*\]~D~^25^ −20, CHCl~3~), ^1^H NMR, and NOESY spectra of **3** recorded in both chloroform and pyridine defined the correlations between H-3, H-6, and H~3~-13 and between H-10 and H~3~-14, all with the same α-orientation, while H~3~-12 and OH-6 adopted a β-orientation ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The absolute configuration was established as (3*R*,6*R*,7*S*,10*R*) by comparing a negative Cotton effect at λ 221 nm (Δε −0.22) and a positive one at λ 287 nm (Δε +0.11) from experimental ECD with the calculated spectra. In view of the spectral data, including those of the acetylated derivative, the structure of **3** was determined as described and named dolichocarpol C.

Compound **4** was isolated as a colorless oil. Its IR spectrum showed a hydroxyl group (3461 cm^--1^) and a carbonyl group (1705 cm^--1^). The C~15~H~26~O~3~ molecular formula was determined by HRESIMS data, *m*/*z* 277.1772 \[M + Na\]^+^ (calcd for C~15~H~26~O~3~Na, 277.1774, Δ = 0.6 ppm). The ^1^H and ^13^C NMR data of **4** ([Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}) were similar to those of **3**, including a carbonyl (δ~C~ 213.2) and two oxymethine carbons (δ~C~ 73.4, 84.6). However, a significant alteration occurred at the quaternary carbinolic carbon C-7 (δ~C~ 69.4, Δ = +14.4 ppm). The HMBC spectrum displayed identical correlations from H~2~-1, H-3, and H-4 to C-2, as in **3** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). The cross-peaks from H-10 to C-15, C-14, and C-1 and from H~3~-13 to C-8, C-7, and C-6 combined with vicinal homonuclear coupling correlations in COSY between H-10 and H~2-~9, between H-7, H-6, and H~2~-5, and between H-3, H~2~-4, and H~3~-12 suggested another type of fusion in the carbon skeleton of **4**. Analysis of the HSQC spectrum allowed an unequivocal establishment of the chemical shifts of C-10 (δ~C~ 73.4) and C-6 (δ~C~ 84.6). Thus, the changes in the chemical shifts were compatible with an ether bridge between C-10 and C-6 instead of C-10 and C-7 ([Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}). As expected, compound **4** could not be acetylated. The ESIMS/MS spectrum of **4** exhibited ion fragments at *m*/*z* 237 \[M - H~2~O + H\]^+^, 219 \[M - 2H~2~O + H\]^+^, and 201 \[M - 3H~2~O + H\]^+^. The negative specific rotation (\[*α*\]~D~^25^ −12, CHCl~3~) and the NOESY correlations observed from H-10 to H~3~-14 and H-3 and from H-14 to H-1α suggest that these protons are cofacial in the α-orientation, whereas the correlations from H~3~-15 to H-1β indicate a β-orientation ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Furthermore, the correlation between H-6 and H~3~-13 accompanied by previous data from the other compounds suggested the α-orientation for these protons and revealed the relative configuration shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. Thus, the structure of compound **4** was suggested as shown and named dolichocarpol D.

Compound **5** was obtained as a colorless oil. Its IR spectrum showed a hydroxyl group (3321 cm^--1^) and a carbonyl group (1659 cm^--1^). The 1D NMR data of compound **5** ([Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}) were similar to those of compounds **1**, **2**, and **4**, altered by the presence of the formyl proton (δ~H~ 9.37, d, *J* = 0.8), as confirmed by HRESIMS at *m*/*z* 275.1622 \[M + Na\]^+^ (calcd for C~15~H~24~O~3~Na, 275.1618, Δ = −1.6 ppm), consistent with a molecular formula of C~15~H~24~O~3~. The general characteristics observed in the ^1^H and ^13^C NMR spectra of **5** were parallel to those of the previous compounds. 2D NMR--HSQC analysis confirmed the chemical shifts for H-10 (δ~H~ 2.90, dd, *J* = 11.2, 1.6 Hz)/C-10 (δ~C~ 72.7), H-6 (δ~H~ 3.58, dd, *J* = 12.4, 5.6 Hz)/C-6 δ~C~ 83.5), and H-2 (δ~H~ 6.52, dd, *J* = 10.8, 7.2 Hz)/C-2 (δ~C~ 152.8). Thus, the ether bridge between C-10 and C-6 was maintained. The localization of the double bond in carbons C-2 and C-3 was defined by HMBC, through the identical sequence of the correlations from H-2 and H-4b to C-12 and from H-12 to C-2 and C-4, like in compound **1** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). In addition, the cross-peaks from H-10 to C-15, C-14, C-8, and C-1 and from H-6 to C-13, C-8, and C-5 corroborated ether bridges C-10 and C-6. The ^1^H--^1^H COSY spectrum exhibited the vicinal coupling between H-2 and H~2~-1, between H-10 and H-9, and between H-6, H-5, and H-4. The negative specific rotation (\[*α*\]~D~^25^ −9, CHCl~3~) and NOESY spectrum showed that the α-orientation was maintained for H-2, H-10, and H~3~-14 as well as for H~3~-13 and H-6, and the relative configuration is shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. From the analysis of the spectral data and comparison with the analogous compounds, the structure of **5** was proposed and named dolichocarpol E.

Compound **6** was isolated as a light brown oil. The IR spectrum showed a hydroxyl group (3444 cm^--1^) and a carbonyl group (1701 cm^--1^). Its molecular formula was determined as C~15~H~24~O~3~ by HRESIMS analysis on the basis of ion *m*/*z* 275.1616 \[M + Na\]^+^ (calcd for C~15~H~24~O~3~Na, 275.1618, Δ = 0.8 ppm), corresponding to four indices of hydrogen deficiency. Unlike for compounds **1**--**5**, the ^1^H NMR spectrum of **6** exhibited only one oxymethine proton at δ~H~ 3.52 (dd, *J* = 6.4, 2.4 Hz) and in addition two oxymethylene protons at δ~H~ 3.66 (d, *J* = 14.0 Hz) and 3.26 (dd, *J* = 14.0, 1.6 Hz). Besides these, there were one methine proton at δ~H~ 2.29 (m) and three methyl protons at δ~H~ 1.23 (s), δ~H~ 1.09 (s), and 1.05 (s) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The ^13^C NMR and DEPT spectra showed a carbonyl group (δ~C~ 215.9), three non-hydrogenated carbons including one oxygenated (δ~C~ 74.1, 50.5, 39.5), methylene carbons (δ~C~ 33.6, 33.0, 32.9, 29.9, 23.7), and methyl carbons (δ~C~ 33.2, 30.6, 29.2). The cross-peaks in HMBC from H~3~-13 to C-8, C-7, C-6, and C-2 suggested a C-C fusion not found in other sesquiterpenoids (**1**--**5**) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Another correlation equally important from H~2~-1 to C-15, C-14, C-10, C-7, C-3, and C-2 defined a new fusion between C-7 and C-2. The HSQC spectrum exhibited the correlation from H~3~-13 to C-13, indicating its insertion in the quaternary carbon C-7 (δ~C~ 50.5), neighboring the carbonyl carbon. Likewise, the HMBC correlation from H~2~-12 to C-10, C-3, and C-2, combined with the sequence of correlations of vicinal homonuclear coupling in COSY between H-10 and H~2~-9, between H~2~-1 and H-2, and between H~2~-4 and H~2~-5, established the ether bridge between C-10 and C-3 via methylene carbon C-12. The ESIMS/MS spectrum showed an ion fragment at *m*/*z* 215 \[M - C~2~H~4~O~2~ + Na\]^+^. The positive specific rotation (\[*α*\]~D~^25^ +10, CHCl~3~) indicates a different orientation for H~3~-13 from those of the compounds shown previously. Furthermore, the NOESY correlation between H-2, H~3~-13, H-8β, H~3~-15, and H-1β suggested that all the protons were cofacial, thus assigned to the β-orientation ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The Cotton effects observed at λ 219 nm (Δε −0.18) and at λ 291 nm (Δε +0.09) allowed establishment of the absolute configuration of **6** as (2*S*,3*R*,7*R*,10*S*) by the comparison of experimental ECD with the calculated data ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). On the basis of these findings, the structure of compound **6** was defined as a new humulene-type sesquiterpene, named dolichocarpol F.

A putative biosynthetic pathway toward compounds **1**--**6** is shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}. Starting from 10-hydroxyhumula-2*E*,6*E*-diene, oxidations occurred producing the hydroxylated intermediate at C-10 and also the epoxidized intermediate at the double bonds Δ^2,3^ and Δ^6,7^. Through successive oxidations and different fusions and cyclizations, compounds **1**--**6** were produced.

![Putative biosynthetic pathway toward compounds **1**--**6**.](ao0c00690_0005){#fig4}

The cytotoxicity of the selected sesquiterpenoids (**3**, **4**, and **6**) against HCT-116 and L929 cell lines was evaluated. Compound **3** significantly inhibited the proliferation of HCT-116 human colon cancer cells at a concentration of 50 μM with an inhibitory rate of 26.63 ± 1.21% ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). No selectivity was observed for **3** toward tumor cells, considering the inhibitory rate against the L929 murine fibroblast nontumor cell line (27.91 ± 0.20%). Compounds **4** and **6** showed weak cytotoxic effects against HCT-116 cells with inhibitory rates under 20%. Moreover, compound **4** exhibited the highest cytotoxicity against L929 nontumor cells (30.76 ± 3.52%).

![Cytotoxicity of compounds **3**, **4**, and **6** against HCT-116 (A) and L929 (B) cells lines, after 72 h of treatment. The values are presented as mean ± standard error for four independent replicates at a concentration of 50 μM (\**p* \< 0.05 compared with untreated cells).](ao0c00690_0006){#fig5}

Experimental Section {#sec3}
====================

General Experiment Procedures {#sec3.1}
-----------------------------

Optical rotations were measured on a Jasco P-2000 polarimeter (Easton, MD, USA) at 25 ° C in CHCl~3~. FTIR spectra were acquired on Bruker Vertex 70 (Bruker, Billerica, MA, USA) and PerkinElmer Frontier (Waltham, MA, USA) spectrometers. 1D- and 2D-NMR spectra were recorded on a Bruker AVANCE III HD 800 MHz spectrometer (800 and 200 MHz for ^1^H and ^13^C, respectively), Varian NMR spectrometer (500 and 125 MHz for ^1^H and ^13^C, respectively), and Bruker AVANCE III HD spectrometer (400 and 100 MHz for ^1^H and ^13^C, respectively) using CHCl~3~ (δ~H~ 7.24 and δ~C~ 77.0), the residual solvent, as an internal standard. High-resolution electrospray ionization mass spectrometry (HRESIMS) and tandem (MS^n^) analyses were carried out using Bruker spectrometers of models micrOTOFII and Ion Trap-amaZonX (Billerica, MA, USA), respectively, both operating in the positive mode. Column chromatography (CC) was performed on a silica gel 60 (60--200 μm, 70--230 mesh, SiliaCycle, Quebec, Canada), and medium-pressure liquid chromatography (MPLC) was performed on a silica gel 60 (40--63 μm, 230--400 mesh, SiliCycle). Thin-layer chromatography (TLC) was carried out using precoated silica gel F-254 aluminum sheets (SiliCycle), and the compound spots were observed under UV light at 254 and 366 nm, staining with iodine vapor. Analytical high-performance liquid chromatography (HPLC) was performed on a Prominence Shimadzu instrument equipped with a SPD-M20A diode array detector and a reversed-phase Phenomenex Gemini C18 column (250 mm × 4.6 mm ID filled with 5 μm particles). For preparative HPLC, a Shimadzu apparatus with an SPD-M10A VP diode array detector and an ACE C18 column (250 mm × 21.2 mm and 5 μm particles) was used with a flow rate of 8.0 mL/min.

Plant Material {#sec3.2}
--------------

The roots of *A. dolichocarpa* were collected from Cruz do Espírito Santo, Paraíba, Brazil (7°09′43.7″S, 35°02′11.1″W) on April 2018. Access registration in the National Management System of Genetic Patrimony and Associated Traditional Knowledge (SISGEN) was obtained under number AE4B71A. A voucher specimen (AGRA & GÓES 5543) was identified by M. F. Agra and deposited at Herbarium Prof. Lauro Pires Xavier (JPB), Federal University of Paraiba (UFPB), Brazil.

Extraction and Isolation {#sec3.3}
------------------------

The air-dried and powdered roots of *A. dolichocarpa* (1.72 kg) were extracted with ethanol for 72 h (3 × 4 L) at room temperature. The extract was concentrated under reduced pressure at 40 ° C to afford 52.6 g of crude extract (CE). Part of CE (49.3 g) was suspended in MeOH-H~2~O (7:3) and sequentially partitioned with hexane, chloroform, and EtOAc. An aliquot of the hexane-soluble portion (8.12 g) was subjected to CC over silica gel, eluting with a gradient of hexane-EtOAc and EtOAc-MeOH, which after TLC analysis were grouped to give the fractions H-1 to H-6. Fraction H-2 (95.0 mg) was subjected to preparative HPLC with the following gradient elution: solvent A = H~2~O; solvent B = MeOH; elution system = 0--40 min (20--70% B); 40--50 min (70% B); and 50--65 min (70--100% B), yielding compound **5** (2.0 mg). Fraction H-4 (85.8 mg) was also subjected to preparative HPLC using gradient elution with H~2~O--MeOH 5 to 100% of MeOH in 75 min to afford compound **1** (1.0 mg). The chloroform-soluble fraction (6.70 g) was separated by MPLC over silica gel using a gradient elution with hexane--EtOAc and EtOAc--MeOH, and the fractions obtained were combined according to the TLC profile to afford C1--C4. The fraction C-2 (197.3 mg) was purified by preparative HPLC with the following elution gradient: solvent A = H~2~O; solvent B = MeOH; elution system = 0--45 min (0--65% B); 45--70 min (65% B); and 70--105 min (65--100% B). This resulted in compounds **2** (0.5 mg), **3** (12.1 mg), **4** (6.8 mg), and **6** (6.0 mg).

Dolichocarpol A (**1**): colorless oil; \[*α*\]~D~^25^ −41 (*c* 0.1, CHCl~3~); ECD (CHCl~3~) λ (Δε) 234 (−0.89), 255 (+0.43); IR (film) ν~max~ 3466, 2955, 2931, 2868, 1706, 1468, 1402, 1213, 1104 cm^--1^; ^1^H and ^13^C NMR data, see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}; positive-ion HRESIMS *m*/*z* 275.1614 \[M + Na\]^+^ (calcd for C~15~H~24~O~3~Na, 275.1618, Δ = 1.2 ppm); positive-ion ESIMS/MS fragments *m*/*z* 257, 217.

Dolichocarpol B (**2**): colorless oil; \[*α*\]~D~^25^ −15 (*c* 0.1, CHCl~3~); ECD (CHCl~3~) λ (Δε) 201 (+1.55), 243 (+1.92); IR (film) ν~max~ 3401, 2958, 2923, 2869, 1703, 1459, 1366, 1214, 1082, 1047 cm^--1^; ^1^H and ^13^C NMR data, see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}; positive-ion HRESIMS *m*/*z* 291.1566 \[M + Na\]^+^ (calcd for C~15~H~24~O~4~Na, 291.1567, Δ = 0.1 ppm); positive-ion ESIMS/MS fragments *m*/*z* 251, 233, 215, 205.

Dolichocarpol C (**3**): colorless oil; \[*α*\]~D~^25^ −20 (*c* 0.1, CHCl~3~); ECD (CHCl~3~) λ (Δε) 221 (−0.22), 287 (+0.11); IR (film) ν~max~ 3458, 2956, 2924, 2873, 1703, 1458, 1367, 1215, 1048 cm^--1^; ^1^H and ^13^C NMR data, see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}; positive-ion HRESIMS *m*/*z* 277.1773 \[M + Na\]^+^ (calcd for C~15~H~26~O~3~Na, 277.1774, Δ = 0.3 ppm); positive-ion ESIMS/MS fragments *m*/*z* 237, 219, 201.

Dolichocarpol D (**4**): colorless oil; \[*α*\]~D~^25^ −12 (*c* 0.1, CHCl~3~); IR (film) ν~max~ 3461, 2960, 2930, 2875, 1705, 1457, 1363, 1214, 1049 cm^--1^; ^1^H and ^13^C NMR data, see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}; positive-ion HRESIMS *m*/*z* 277.1772 \[M + Na\]^+^ (calcd for C~15~H~26~O~3~Na, 277.1774, Δ = 0.6 ppm); positive-ion ESIMS/MS fragments *m*/*z* 237, 219, 201.

Dolichocarpol E (**5**): colorless oil; \[*α*\]~D~^25^ −9 (*c* 0.1, CHCl~3~); IR (film) ν~max~ 3321, 2975, 2929, 2883, 1659, 1453, 1383, 1270, 1082, 1045 cm^--1^; ^1^H and ^13^C NMR data, see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}; positive-ion HRESIMS *m*/*z* 275.1622 \[M + Na\]^+^ (calcd for C~15~H~24~O~3~Na, 275.1618, Δ = −1.6 ppm).

Dolichocarpol F (**6**): colorless oil; \[*α*\]~D~^25^ +10 (*c* 0.1, CHCl~3~); ECD (CHCl~3~) λ (Δε) 219 (−0.18), 291 (+0.09); IR (film) ν~max~ 3344, 2954, 2923, 2867, 1701, 1462, 1368, 1213, 1092 cm^--1^; ^1^H and ^13^C NMR data, see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}; positive-ion HRESIMS *m*/*z* 275.1616 \[M + Na\]^+^ (calcd for C~15~H~24~O~3~Na, 275.1618, Δ = 0.8 ppm); positive-ion ESIMS/MS fragments *m*/*z* 215.

ECD Calculation {#sec3.4}
---------------

Conformational studies for compounds **1**--**6** were carried out on the Spartan'16 software using the MMFF94 molecular mechanics force field calculation. Conformers within a 10 kcal/mol energy window were generated and further optimized using density functional theory (DFT) calculation at the B3LYP/6-31G\*(d) level. The conformers with over 1% of Boltzmann distribution were chosen for ECD calculation at the B3LYP/6-311+G(2d,p) level. The calculated ECD spectra were obtained by DFT and time-dependent DFT (TD-DFT) using Gaussian 09 and analyzed on SpecDis v1.71.

Cytotoxicity Assay {#sec3.5}
------------------

Human colon cancer HCT-116 cells and nontumor murine fibroblast L929 cells were cultured in an RPMI-1640 medium containing 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C with 5% CO~2~ in a humidified atmosphere. Cells were seeded in 96 well plates at a density of 3 × 10^5^ cells per well. Following a 24 h period, cells were incubated with the sesquiterpenoids (**3**, **4**, and **6**) (50 μM) dissolved in DMSO (0.4%). After culturing for 72 h, 10 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (5 mg/mL) was added and incubated for another 4 h. The deposited formazan was dissolved with dodecyl sulfate sodium salt (100 μL).^[@ref27]^ Positive control was DMSO (20%). The optical densities were measured using a microplate spectrophotometer (Microplate reader BioTek Instruments, Sinergy HT, Winooski, VT, USA). Data were analyzed with GraphPad Prism 5.0 using the analysis of variance (one-way ANOVA).

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c00690](https://pubs.acs.org/doi/10.1021/acsomega.0c00690?goto=supporting-info).HRESIMS, IR, NMR, and ESIMS/MS data of compounds **1**--**6** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00690/suppl_file/ao0c00690_si_001.pdf))
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